Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Targeting Androgen Receptor with Boesenbergia rotunda Phytoconstituents: A Computational-based Perspective

Indonesian Journal of Cancer Chemoprevention · Vol. 16 No. 1 (2025) · hlm. 29–43

DOI
10.14499/indonesianjcanchemoprev16iss1pp29-43
ISSN
2355-8989, 2088-0197
Terbit
2025-02-28
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Prostate cancer is characterized by abnormal cell proliferation within the prostate gland, driven in part by the activation of androgen receptor (AR) upon binding with testosterone. The receptor, therefore, represents a critical therapeutic target in prostate cancer management. Boesenbergia rotunda or fingerroot (or temu kunci in Indonesia), a medicinal plant widely used in traditional medicine, has been reported to exhibit diverse pharmacological activities, including anticancer effects. However, despite these promising bioactivities, no molecular level or computational studies have been conducted to explore its interaction with AR. In this study, the anticancer potential of eighteen secondary metabolites from B. rotunda rhizome was investigated in silico against the AR to identify new therapeutic candidates. The test ligands were evaluated for their physicochemical properties in accordance with Lipinski’s rule of five, ADME/Tox predictions, pharmacophore screening, and molecular docking, in comparison with the reference drug bicalutamide. Among the evaluated compounds, boesenbergin A demonstrated the strongest binding affinity to AR, with a binding energy of –11.89 kcal/ mol and an inhibition constant of 1.92 nM. Importantly, boesenbergin A engaged amino acid residues, including TRP: 741, like bicalutamide, indicating comparable binding interactions. These findings suggest that boesenbergin A holds substantial promise as a natural anticancer lead compound targeting the AR and warrants further investigation as a potential therapeutic agent for prostate cancer.Keywords: Boesenbergia rotunda, boesenbergin A, prostate cancer, in silico.

Jaringan kolaborasi para penulis

38 penulis · 130 tautan kepenulisan bersama · 36 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Padjadjaran University
  • Universitas Garut
  • Universitas Jember
  • Kementerian Kesehatan Republik Indonesia
  • Nara Institute of Science and Technology
  • Indonesian Institute of Sciences
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Edy MeiyantoUniversitas Gadjah Mada4
Riris Istighfari JenieUniversitas Gadjah Mada2
Nunuk PurwantiUniversitas Gadjah Mada1
Banun KusumawardaniUniversitas Jember1
Dwi Merry Christmarini RobinUniversitas Gadjah Mada1
Retno ArdhaniUniversitas Gadjah Mada1
Faaza Aulia RahmanUniversitas Gadjah Mada1
Adam HermawanUniversitas Gadjah Mada1
Laeli MuntafiahUniversitas Gadjah Mada1
Nur Fitra SariUniversitas Gadjah Mada1
Muchtaridi MuchtaridiPadjadjaran University1
Nawadhir FauzanPadjadjaran University1
Riska PrasetiawatiUniversitas Garut1
Meilia SuhermanUniversitas Garut1
Ediati SasmitoUniversitas Gadjah Mada1
Sari HaryantiKementerian Kesehatan Republik Indonesia1
Herwandhani PutriUniversitas Gadjah Mada1
Beni LestariUniversitas Gadjah Mada1
Jun‐ya KatoNara Institute of Science and Technology1
Nazwa Septiriana PutriAfiliasi tidak diketahui1
Ghina Alya Putri QurrotaayunPadjadjaran University1
Joy Elizabeth Nauli SitompulPadjadjaran University1
Naya FadhilahPadjadjaran University1
Fransisca Widi PramuditaPadjadjaran University1
Fajar Oktavian MuljonoPadjadjaran University1
Firghi Muhammad FardhanPadjadjaran University1
Retno MurwantiUniversitas Gadjah Mada1
Devyanto Hadi TriutomoUniversitas Gadjah Mada1
Fitriana Hayyu ArifahUniversitas Gadjah Mada1
Anselma IvanawatiUniversitas Gadjah Mada1
Zahrotul UlumUniversitas Gadjah Mada1
Sri HandayaniIndonesian Institute of Sciences1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Targeting Androgen Receptor with Boesenbergia rotunda Phytoconstituents: A Computational-based Perspective</dc:title>
	<dc:creator>Widarso, Najla Yasmintia</dc:creator>
	<dc:creator>Mahwati, Ari Anggi</dc:creator>
	<dc:creator>Sibuea, Irene Ivory</dc:creator>
	<dc:creator>Ismail, Dzava Prawinsyah Fairus</dc:creator>
	<dc:creator>Mahardika, Bintang Satrio</dc:creator>
	<dc:creator>Novitasari, Dhania</dc:creator>
	<dc:description xml:lang="en-US">Prostate cancer is characterized by abnormal cell proliferation within the prostate gland, driven in part by the activation of androgen receptor (AR) upon binding with testosterone. The receptor, therefore, represents a critical therapeutic target in prostate cancer management. Boesenbergia rotunda or fingerroot (or temu kunci in Indonesia), a medicinal plant widely used in traditional medicine, has been reported to exhibit diverse pharmacological activities, including anticancer effects. However, despite these promising bioactivities, no molecular level or computational studies have been conducted to explore its interaction with AR. In this study, the anticancer potential of eighteen secondary metabolites from B. rotunda rhizome was investigated in silico against the AR to identify new therapeutic candidates. The test ligands were evaluated for their physicochemical properties in accordance with Lipinski’s rule of five, ADME/Tox predictions, pharmacophore screening, and molecular docking, in comparison with the reference drug bicalutamide. Among the evaluated compounds, boesenbergin A demonstrated the strongest binding affinity to AR, with a binding energy of –11.89 kcal/ mol and an inhibition constant of 1.92 nM. Importantly, boesenbergin A engaged amino acid residues, including TRP: 741, like bicalutamide, indicating comparable binding interactions. These findings suggest that boesenbergin A holds substantial promise as a natural anticancer lead compound targeting the AR and warrants further investigation as a potential therapeutic agent for prostate cancer.Keywords: Boesenbergia rotunda, boesenbergin A, prostate cancer, in silico.</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2025-02-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/543</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev16iss1pp29-43</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 16, No 1 (2025); 29-43</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/543/323</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>